
About ExRNA
Manuscript Submission
AME Editing Service
Reprint & Permission
Advertising
Contact us
-
General editorial enquiries:
Email: exrna@amepc.org -
Copyright related contact:
Email: permissions@amegroups.com -
Commercial Sales contact (Reprints, advertising, etc.):
Email: sales@amegroups.com
Editorial Commentary
ExRNA
2022;
4:
11
(29 April 2022)
Editorial Commentary
ExRNA
2022;
4:
10
(29 April 2022)
Editorial Commentary
ExRNA
2022;
4:
9
(31 March 2022)
Editorial Commentary
ExRNA
2022;
4:
8
(31 March 2022)
Editorial Commentary
ExRNA
2022;
4:
7
(31 March 2022)
Editorial Commentary
ExRNA
2022;
4:
6
(28 February 2022)
Editorial Commentary
ExRNA
2022;
4:
5
(28 February 2022)
Editorial Commentary
ExRNA
2022;
4:
4
(28 February 2022)
Editorial Commentary
ExRNA
2022;
4:
3
(25 January 2022)
Editorial Commentary
ExRNA
2022;
4:
2
(25 January 2022)
Editorial Commentary
ExRNA
2022;
4:
1
(25 January 2022)
Editorial Commentary
ExRNA
2021;
4:
14
(30 December 2021)
Editorial Commentary
ExRNA
2021;
4:
13
(30 December 2021)
Editorial Commentary
ExRNA
2021;
4:
12
(30 December 2021)
Editorial Commentary
ExRNA
2021;
4:
11
(30 December 2021)
Editorial Commentary
ExRNA
2021;
4:
10
(30 December 2021)
Editorial Commentary
ExRNA
2021;
4:
9
(30 November 2021)
Editorial Commentary
ExRNA
2021;
4:
8
(30 November 2021)
Editorial Commentary
ExRNA
2021;
4:
7
(30 November 2021)
Editorial Commentary
ExRNA
2021;
4:
6
(30 November 2021)